Skip to main content
Premium Trial:

Request an Annual Quote

SurroMed, Relocating to PPD s Digs, Trades Stock for Cancer Markers

Click here for an updated version of this story.


NEW YORK, July 17 - PPD has given SurroMed an undisclosed cash payment and a range of cancer biomarkers in exchange for $24 million worth of SurroMed's senior preferred stock, the companies said today.


SurroMed said it intends to use PPD's biomarkers to take a stab at cancer diagnostics, and that it also plans to seek to partner related cancer therapeutic opportunities."


PPD has also bought biomarker-discovery services from SurroMed over the next four years, and will become SurroMed's "non-exclusive representative" for sales of additional biomarker-discovery services.

Terms of the transaction also call for SurroMed to relocate to PPD's facility in Menlo Park, Calif. The transactions are expected to close next month.

"We believe that the collaboration with PPD will allow SurroMed to achieve positive cash flow and sustainability and to expand our leadership position in the field of biomarker discovery," Gordon Ringold, CEO and chairman of SurroMed, said in a statement.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.